APEX: Executive Training and Brain in Children
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether a daily executive training to cognitive inhibition, working memory or mindfulness as compared to an active control condition has a near- and far-transfer impact on brain and behavioral measures as collected in children aged 9-10 years, either born preterm or full-term.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Preterm Inhibition In children born very preterm: Inhibition training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing |
Behavioral: Inhibition training
Inhibition training on a tactile tablet for a month (20 sessions of 15 min)
Genetic: Saliva collection
Collection of a saliva sample for genotyping
Procedure: Brain Magnetic Resonance Imaging
Structural and functional MRI
Behavioral: Cognitive testing
Battery of cognitive and academic tasks on executive functions
|
Experimental: Full-term Inhibition In children born full-term: Inhibition training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing |
Behavioral: Inhibition training
Inhibition training on a tactile tablet for a month (20 sessions of 15 min)
Genetic: Saliva collection
Collection of a saliva sample for genotyping
Procedure: Brain Magnetic Resonance Imaging
Structural and functional MRI
Behavioral: Cognitive testing
Battery of cognitive and academic tasks on executive functions
|
Experimental: Full-term Working memory In children born full-term: Working memory training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing |
Behavioral: Working memory training
Working memory training on a tactile tablet for a month (20 sessions of 15 min)
Genetic: Saliva collection
Collection of a saliva sample for genotyping
Procedure: Brain Magnetic Resonance Imaging
Structural and functional MRI
Behavioral: Cognitive testing
Battery of cognitive and academic tasks on executive functions
|
Experimental: Full-term Mindfulness In children born full-term: Mindfulness training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing |
Behavioral: Mindfulness training
Mindfulness training on a tactile tablet for a month (20 sessions of 15 min)
Genetic: Saliva collection
Collection of a saliva sample for genotyping
Procedure: Brain Magnetic Resonance Imaging
Structural and functional MRI
Behavioral: Cognitive testing
Battery of cognitive and academic tasks on executive functions
|
Active Comparator: Full-term Active control In children born full-term: Active control training, Saliva collection, Brain Magnetic Resonance Imaging, Cognitive testing |
Behavioral: Active control training
Active control training on a tactile tablet for a month (20 sessions of 15 min)
Genetic: Saliva collection
Collection of a saliva sample for genotyping
Procedure: Brain Magnetic Resonance Imaging
Structural and functional MRI
Behavioral: Cognitive testing
Battery of cognitive and academic tasks on executive functions
|
Outcome Measures
Primary Outcome Measures
- Change in brain functional BOLD activity after one month of executive training as assessed by MRI in regions subtending executive functioning. [3 months: Pretest (t0), immediate Post-test (t0+1 month), deferred post-test (t0+3 months)]
Change in brain activation will be measured with functional magnetic resonance imaging (fMRI) during two different tasks: a Stop Signal task assessing inhibition and a Dot task assessing working memory.
- Change in brain cortical structure after one month of executive training as assessed by anatomical MRI in regions subtending executive functioning. [3 months: Pretest (t0), immediate Post-test (t0+1 month), deferred post-test (t0+3 months)]
Change in brain cortical structure will be measured with anatomical magnetic resonance imaging (aMRI) using four different measures: 2.a. grey matter volume 2.b. cortical thickness 2.c. cortical surface area 2.d. curvature
- Change in cognitive behavioral measures after one month of executive training as assessed by cognitive testing [3 months: Pretest (t0), immediate Post-test (t0+1 month), deferred post-test (t0+3 months)]
The cognitive testing session includes several tasks assessing executive functioning under different conditions. Will be investigated: 3.a. Response Time 3.b. Accuracy
Secondary Outcome Measures
- Sulcal morphometry measured by anatomical MRI [Pretest (t0)]
Assessing the impact of the early determined sulcal morphometry on behavioral and brain changes associated to a one-month executive training.
- Genetic variations measured by Single Nucleotide Polymorphism (SNP) genotyping [Pretest (t0)]
Assessing the impact of the different genotypes on behavioral and brain changes associated to a one-month executive training.
Eligibility Criteria
Criteria
Inclusion Criteria for all children:
-
Male or female
-
Aged 9-10 years at inclusion
-
French school curriculum (since 1st grade)
-
Fully informed through the dedicated booklet
-
Both parents gave their written consent
-
Normal medical, neurological and brain imaging assessment
Inclusion criterion for non preterm children only:
- Full term pregnancy with no abnormal event (>= 37 weeks of amenorrhea)
Inclusion criterion for preterm children only:
- Delivery before 33 weeks of amenorrhea
Exclusion Criteria for all participants:
-
Age over or under 9-10 years old at inclusion
-
Monozygotic twins
-
Restrictions to a Magnetic Resonance brain imaging exam: claustrophobia, metallic elements (cardiac implants, cochlear implants, metallic elements in the brain or the eyes and being close to the nervous system, metallic prothesis, braces), restless participants.
-
Sudden cognitive impairments due to a stroke, head injury associated with loss of consciousness for more than one hour or encephalitis.
-
Chronic neurological, psychiatric, infectious or liver condition, endocrine disruption.
-
Past or current medical condition: cancer, diabetes, chronic lung condition, cardiac, metabolic, hematological, endocrine or immunological disorder.
-
Medication assumed to interfere with brain imaging measures (psychotropics, hypnotics, anxiolytics, neuroleptics, benzodiazepine, steroidal anti-inflammatory, anti-epileptics, painkillers, muscle relaxants).
-
Left-sided handedness
-
Colour blindness or non-corrected visual disturbances
-
Diagnosed developmental disorders
-
Diagnosed cerebral palsy
-
Diagnosed Fine motor disturbances
-
Parents not affiliated to the Social Security
-
Parents not able to join at each time of the study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | GIP Cyceron | Caen | France | 14074 |
Sponsors and Collaborators
- University Hospital, Caen
- National Research Agency, France
Investigators
- Principal Investigator: Olivier Houdé, Professor, University of Paris 5 - Rene Descartes
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2015-A00383-46
- 15-045